CanniMed Therapeutics Inc. is a listed company. Filings by its managers are published through SEDI. The past year has been quiet: not a single insider filing for CanniMed Therapeutics Inc. The previous disclosure was published on 27 March 2018.
Our records for CanniMed Therapeutics Inc. go back to 2016, with 5 purchases and 13 sales on the open market in total.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 75 declarations
CanniMed Therapeutics Inc. is a Canadian company specializing in the production of cannabis-based products. It is listed on the Toronto Stock Exchange under the symbol XTSE.